Volume 99 Number 6
Published online 9 September 2008 (841 - 988)
---------------------------------------------------------------------
This alert is sponsored by Agilent Technologies
Insights Into Genetic Variation
See how microarray-based CNV research is changing our understanding of
genetic variation. Visit OpenGenomics to watch CNV presentations and
read the latest papers from leading researchers. While you're there,
register for information on upcoming CNV products and promotions.
http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5AO0EI
---------------------------------------------------------------------
British Journal of Cancer publishes high quality original papers and
reviews that make a significant contribution to increasing
understanding of the causes of cancer and to improving the treatment
and survival of patients.
Visit the journal online at
http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0KWT0Ez
to view the latest research and access selected articles FREE of charge.
---------------------------------------------------------------------
British Journal of Cancer has an impact factor 4.635 * and is ranked
27/132 in Oncology*.
*2007 Journal Citation Report (Thomson Reuters, 2008)
---------------------------------------------------------------------
----------------------
MINIREVIEWS
----------------------
Biomarkers of apoptosis
T H Ward, J Cummings, E Dean, A Greystoke, J M Hou, A Backen, M Ranson
and C Dive
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5AP0EJ
Article: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5AQ0EK
Fusion in the ETS gene family and prostate cancer
S A Narod, A Seth and R Nam
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5AR0EL
Article: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5AS0EM
----------------------
CLINICAL STUDIES
----------------------
A randomised phase II trial of preoperative chemotherapy of
cisplatin-docetaxel or docetaxel alone for clinical stage IB//II
non-small-cell lung cancer: results of a Japan Clinical Oncology Group
trial (JCOG 0204)
H Kunitoh, H Kato, M Tsuboi, H Asamura, H Tada, K Nagai, T Mitsudomi,
T Koike, K Nakagawa, Y Ichinose, M Okada, T Shibata and N Saijo
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5AT0EN
Article: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5AU0EO
Phase II study of short-time oxaliplatin, capecitabine and epirubicin
(EXE) as first-line therapy in patients with non-resectable gastric
cancer
K R Schonnemann, H A Jensen, M Yilmaz, B V Jensen, O Larsen and P
Pfeiffer
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5AV0EP
Article: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5AW0EQ
Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a
phase II study
T Andre, J M Reyes-Vidal, L Fartoux, P Ross, M Leslie, O Rosmorduc, M
R Clemens, C Louvet, N Perez, F Mehmud and W Scheithauer
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5AX0ER
Article: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5AY0ES
Phase I study of epirubicin, cisplatin and capecitabine plus matuzumab
in previously untreated patients with advanced oesophagogastric cancer
S Rao, N Starling, D Cunningham, M Benson, A Wotherspoon, C Lupfert, R
Kurek, J Oates, J Baselga and A Hill
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5AZ0ET
Article: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5Aa0Ea
Clinician and cancer patient views on patient participation in
treatment decision-making: a quantitative and qualitative exploration
A H Pieterse, M C M Baas-Thijssen, C A M Marijnen and A M Stiggelbout
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5Ab0Eb
Article: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5Ac0Ec
Modelling prognostic factors in advanced pancreatic cancer
D D Stocken, A B Hassan, D G Altman, L J Billingham, S R Bramhall, P J
Johnson and N Freemantle
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5Ad0Ed
Article: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5Ae0Ee
Estimation of renal function and its potential impact on carboplatin
dosing in children with cancer
G Chinnaswamy, M Cole, A V Boddy, M Keir, L Price, A Parry, M English
and G J Veal
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5Af0Ef
Article: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5Ag0Eg
----------------------
TRANSLATIONAL THERAPEUTICS
----------------------
Image-guided and passively tumour-targeted polymeric nanomedicines for
radiochemotherapy
T Lammers, V Subr, P Peschke, R Kuhnlein, W E Hennink, K Ulbrich, F
Kiessling, M Heilmann, J Debus, P E Huber and G Storm
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5Ah0Eh
Article: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5Ai0Ei
Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated
erlotinib-resistant lung cancer
Z Tang, R Du, S Jiang, C Wu, D S Barkauskas, J Richey, J Molter, M
Lam, C Flask, S Gerson, A Dowlati, L Liu, Z Lee, B Halmos, Y Wang, J A
Kern and P C Ma
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5Aj0Ej
Article: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5Ak0Ek
----------------------
MOLECULAR DIAGNOSTICS
----------------------
Comparison of EGFR and K-RAS gene status between primary tumours and
corresponding metastases in NSCLC
A Kalikaki, A Koutsopoulos, M Trypaki, J Souglakos, E Stathopoulos, V
Georgoulias, D Mavroudis and A Voutsina
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5Al0El
Article: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5Am0Em
Chemokine CXCL13 is overexpressed in the tumour tissue and in the
peripheral blood of breast cancer patients
J Panse, K Friedrichs, A Marx, Y Hildebrandt, T Luetkens, K Bartels, C
Horn, T Stahl, Y Cao, K Milde-Langosch, A Niendorf, N Kroger, S
Wenzel, R Leuwer, C Bokemeyer, S Hegewisch-Becker and D Atanackovic
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5An0En
Article: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5Ao0Eo
GOLPH2 protein expression as a novel tissue biomarker for prostate
cancer: implications for tissue-based diagnostics
G Kristiansen, F R Fritzsche, K Wassermann, C Jager, A Tolle, M Lein,
C Stephan, K Jung, C Pilarsky, M Dietel and H Moch
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5Ap0Ep
Article: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5Aq0Eq
Deregulation of MUC4 in gastric adenocarcinoma: potential
pathobiological implication in poorly differentiated non-signet ring
cell type gastric cancer
S Senapati, P Chaturvedi, P Sharma, G Venkatraman, J L Meza, W
El-Rifai, H K Roy and S K Batra
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5Ar0Er
Article: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5As0Es
Smad7 induces hepatic metastasis in colorectal cancer
S K Halder, G Rachakonda, N G Deane and P K Datta
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5At0Et
Article: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5Au0Eu
----------------------
GENETICS AND GENOMICS
----------------------
Reduced expression of a gene proliferation signature is associated
with enhanced malignancy in colon cancer
A Anjomshoaa, Y-H Lin, M A Black, J L McCall, B Humar, S Song, R
Fukuzawa, H-S Yoon, B Holzmann, J Friederichs, A van Rij, M
Thompson-Fawcett and A E Reeve
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5Av0Ev
Article: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5Aw0Ew
An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as
breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriers
A Osorio, M Pollan, G Pita, R K Schmutzler, B Versmold, C Engel, A
Meindl, N Arnold, S Preisler-Adams, D Niederacher, W Hofmann, D
Gadzicki, A Jakubowska, U Hamann, J Lubinski, A Toloczko-Grabarek, C
Cybulski, T Debniak, G Llort, D Yannoukakos, O Diez, B Peissel, P
Peterlongo, P Radice, T Heikkinen, H Nevanlinna, P L Mai, J T Loud, L
McGuffog, A C Antoniou and J Benitez
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5Ax0Ex
Article: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5Ay0Ey
Genetic regulation of MUC1 alternative splicing in human tissues
W Ng, A X W Loh, A S Teixeira, S P Pereira and D M Swallow
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5Az0Ez
Article: http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5A10Em
----------------------
LETTERS TO THE EDITOR
----------------------
Early onset of breast cancer in Black British women: how reliable are
the findings[quest]
J D Ingleby
http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5A20En
Reply: Early onset of breast cancer in black British women: how
reliable are the findings[quest]
S W Duffy, R L Bowen, D A Ryan, I R Hart and J L Jones
http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B5A30Eo
---------------------------------------------------------------------
Ensure your access to British Journal of Cancer
If you are unable to access the articles in this Table of Contents
e-alert, your library may not subscribe to this journal. Our online
recommendation form is a simple way to make your librarian aware that
this journal is valuable to your research.
Recommend now at
http://ealerts.nature.com/cgi-bin24/DM/y/enRS0Xztnp0Hhi0B4BJ0ED
======================================================================
You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne -
San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and
Wales under company number 785998 and whose registered office is located
at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.
(c) Copyright 2008 Nature Publishing Group
======================================================================
